Tag: India Coronavirus
-
India administers one million vaccine doses against Covid-19
India started its vaccination drive on January 16 and a week later, the country has administered more than one million vaccine shots to people against Covid-19 virus. With this achievement, India has become the fastest country to cross the mark of a million doses among all the countries that have started the vaccination drive. The ... -
PM Modi launched the largest vaccination against coronavirus today
The largest vaccination drive against coronavirus in the world has been launched by Prime Minister Narendra Modi on January 16. Under this vaccination drive, nearly three lakh healthcare workers are aimed to be vaccinated. On its first day, there are 3,006 vaccination sites installed all over the country. In the wake of growing cases in ... -
After announcing vaccination drive from Jan 16, centre to take call on shipping facilities
Shipping Facilities: The government announced that the vaccination drive in India will commence from January 16 and now it is finalising the shipping facilities and other such needs to ensure supply of vaccines to every state. This will be the largest vaccination drive in the world against coronavirus where nearly 30 million people will be ... -
Five Indian states see increase in the coronavirus case while some see a steady decline
Coronavirus Case: The threat of the coronavirus refuses to be diffused in India and many other parts of the world but there are some states that are experiencing far more threats than the rest. In India, there are five states which have seen a rise in the number of active cases revealing government’s data. As ... -
What is ‘Mission Covid Suraksha’ launched by the government?
Mission Covid Suraksha: The Indian government launched a new initiative in the wake of the coronavirus pandemic called ‘Mission Covid Suraksha’ on Wednesday. This initiative will facilitate the development process of nearly five to six vaccine candidates in the country which means the procedure will be accelerated. Through this project, it will be easier for ... -
India’s covid-19 cases reaches all time low, Vaccine development also shows optimism
India’s covid-19 cases reaches low: It has been over a month that India has been witnessing a fall in the number of coronavirus cases and even now the series seems to be consistent as the covid-19 count falls 29,163 on Tuesday. As per the data given by the Union Health Ministry, the tally of the ... -
India to get first AYUSH-approved ayurvedic COVID-19 drug
India to get first AYUSH-approved ayurvedic COVID-19 drug: YUSH Ministry has approved the manufacture of an ayurvedic drug for treatment of COVID-19 disease Dalmia Healthcare is all set to launch a polyherbal combination of 15 herbs called Astha-15 for the treatment of COVID-19 disease. Its research centre, Dalmia Centre for Research and Development (DCRD), has ... -
WHO chief thanks PM Modi for commitment towards fighting coronavirus
WHO chief thanks PM Modi: Tedros Adhanon Ghebreyesus, WHO Chief tweeted thanking the PM Modi for his efforts to fight Covid-19 pandemic by supporting Cova, a vaccine that is initiated by WHO and Gavi. He also welcomed India’s leading role in global health and universal health coverage. “The pandemic is an unprecedented challenge for the ... -
‘Will take more than a year for vaccine to be available for normal people,’ says AIIMS Director
Common people will have to wait till 2022 to get a shot of the coronavirus vaccine, confirms the AIIMS director Randeep Guleria. In an interview to CNN-News18, the director who is also a part of the National Task Force designated to handle the coronavirus crisis in the country said it will take “more than a ... -
India to make Covaxin available in Q2 2021: Reports
As per the official reports, the first vaccine being developed in India–Covaxin will be launched by the second quarter next year. The company official confirmed that once it is approved the vaccine will be made available to the public. “If we get all the approvals after establishing strong experimental evidence and data, and efficacy and ...